July 20, 2026

LSD1-GLS2 axis drives subtype-specific chemoresistance in pancreatic cancer through glutaminolysis reprogramming – Nature

July 19, 2026

A Pancreatic Cancer Vaccine Shows Promise in a Phase 1 Clinical Trial – the-scientist.com

July 17, 2026

Pancreatic Cancer Vaccine Triggers Immune Response Before Tumors Develop – Inside Precision Medicine

July 16, 2026

Experimental KRAS Vaccine Generates Immune Response Against Pancreatic Cancer in People at High Risk – Johns Hopkins Medicine

July 16, 2026

From Treatment to Prevention: How Vaccines Are Reshaping the Fight Against Pancreatic Cancer